Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Henderson

OPKO Health has appointed Gregory Henderson as president of Bio-Reference Laboratories (BRL), acquired by OPKO Health in August 2015. Henderson succeeds Marc Grodman, who is resigning, having served as chairman, president and CEO of BRL. He joins BRL from the Mount Sinai Health Network, where he was the vice chairman of pathology outreach and affiliate laboratory affairs. Henderson also founded and sold two large regional clinical lab businesses: NextWave Diagnostic Laboratory in Wilmington, N.C. and Pacific Pathology Partners in Seattle.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.